Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30239% above fair value
$132.81−4.97 (-3.61%)
Close on Nov 19, 2026Market cap $327.67BP/E 106.2Yield 2.47%
Merck shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Merck's shares outstanding was 2.47B at Jun 30, 2026. For fiscal 2025 it was 2.51B, down 1.3% from the year before. Over ten years it grew -1.2% a year on average. The highest annual figure on record is 3.09B in fiscal 2011.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.51B | -1.3% |
| FY2024 | Dec 31, 2024 | 2.54B | -0.2% |
| FY2023 | Dec 31, 2023 | 2.55B | +0.2% |
| FY2022 | Dec 31, 2022 | 2.54B | +0.2% |
| FY2021 | Dec 31, 2021 | 2.54B | -0.1% |
| FY2020 | Dec 31, 2020 | 2.54B | -1.5% |
| FY2019 | Dec 31, 2019 | 2.58B | -3.7% |
| FY2018 | Dec 31, 2018 | 2.68B | -2.5% |
| FY2017 | Dec 31, 2017 | 2.75B | -1.4% |
| FY2016 | Dec 31, 2016 | 2.79B | -1.9% |
| FY2015 | Dec 31, 2015 | 2.84B | -3.0% |
| FY2014 | Dec 31, 2014 | 2.93B | -2.3% |
| FY2013 | Dec 31, 2013 | 3.00B | -2.6% |
| FY2012 | Dec 31, 2012 | 3.08B | -0.6% |
| FY2011 | Dec 31, 2011 | 3.09B | +99166566.7% |
| FY2010 | Dec 31, 2010 | 0M | -100.0% |
| FY2009 | Dec 31, 2009 | 2.27B | +6.1% |
| FY2008 | Dec 31, 2008 | 2.14B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2.47B | -1.7% |
| Q1 FY2026 | Mar 31, 2026 | 2.47B | -2.3% |
| Q4 FY2025 | Dec 31, 2025 | 2.49B | -1.9% |
| Q3 FY2025 | Sep 30, 2025 | 2.50B | -1.7% |
| Q2 FY2025 | Jun 30, 2025 | 2.51B | -1.2% |
| Q1 FY2025 | Mar 31, 2025 | 2.53B | -0.5% |
| Q4 FY2024 | Dec 31, 2024 | 2.54B | -0.2% |
| Q3 FY2024 | Sep 30, 2024 | 2.54B | -0.2% |
| Q2 FY2024 | Jun 30, 2024 | 2.54B | +0.2% |
| Q1 FY2024 | Mar 31, 2024 | 2.54B | -0.3% |
| Q4 FY2023 | Dec 31, 2023 | 2.54B | -0.3% |
| Q3 FY2023 | Sep 30, 2023 | 2.55B | +0.2% |
| Q2 FY2023 | Jun 30, 2023 | 2.54B | -0.0% |
| Q1 FY2023 | Mar 31, 2023 | 2.55B | +0.6% |
| Q4 FY2022 | Dec 31, 2022 | 2.55B | +0.5% |
| Q3 FY2022 | Sep 30, 2022 | 2.54B | +0.2% |
| Q2 FY2022 | Jun 30, 2022 | 2.54B | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | 2.54B | -0.2% |
| Q4 FY2021 | Dec 31, 2021 | 2.54B | -0.2% |
| Q3 FY2021 | Sep 30, 2021 | 2.54B | -0.1% |
| Q2 FY2021 | Jun 30, 2021 | 2.54B | +0.2% |
| Q1 FY2021 | Mar 31, 2021 | 2.54B | -0.2% |
| Q4 FY2020 | Dec 31, 2020 | 2.54B | -0.7% |
| Q3 FY2020 | Sep 30, 2020 | 2.54B | -1.3% |
| Q2 FY2020 | Jun 30, 2020 | 2.54B | -2.0% |
| Q1 FY2020 | Mar 31, 2020 | 2.55B | -2.2% |
| Q4 FY2019 | Dec 31, 2019 | 2.56B | -2.8% |
| Q3 FY2019 | Sep 30, 2019 | 2.57B | -4.0% |
| Q2 FY2019 | Jun 30, 2019 | 2.59B | -4.0% |
| Q1 FY2019 | Mar 31, 2019 | 2.60B | -3.9% |
| Q4 FY2018 | Dec 31, 2018 | 2.63B | -3.5% |
| Q3 FY2018 | Sep 30, 2018 | 2.68B | -1.8% |
| Q2 FY2018 | Jun 30, 2018 | 2.70B | -2.0% |
| Q1 FY2018 | Mar 31, 2018 | 2.71B | -2.0% |
| Q4 FY2017 | Dec 31, 2017 | 2.73B | -1.6% |
| Q3 FY2017 | Sep 30, 2017 | 2.73B | -2.1% |
| Q2 FY2017 | Jun 30, 2017 | 2.75B | – |
| Q1 FY2017 | Mar 31, 2017 | 2.77B | – |
| Q4 FY2016 | Dec 31, 2016 | 2.77B | – |
| Q3 FY2016 | Sep 30, 2016 | 2.79B | – |
See a number that looks wrong?